Q3 2014
Released Nov 10, 2014, before the open
10-Q filed Nov 10, 2014, 41 days after period end · 0001144204-14-066218
Q3 2014 · 10-Q
Revenue—
Net Income-$4.09M-$4.09M N/M vs Q3 2013N/M vs Q2 2014
EPS Diluted-$0.32-$0.32 N/M vs Q3 2013N/M vs Q2 2014
Operating Income-$4,118,351N/M
Operating Cash Flowderived-$2,477,175N/M
Free Cash Flowderived-$2,496,589N/M
What the release said
The release
Same quarter
| Metric | Q3 2014 | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $0.00 |
| Net Income | -$4.09M | -$3.48M | -$1.01M | $0.00 |
| EPS Diluted | -$0.32 | -$0.39 | -$0.23 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR